Belapectin
Product Specifications
Product Name Alternative
Prodigiosine (hydrochloride)
UNSPSC Description
Belapectin (GR-MD-02) is a Galectin-3 (Gal-3) inhibitor. Belapectin drives tumor-induced immunosuppression by inducing T cell Apoptosis. Belapectin promotes tumor regression and improves survival of tumor-bearing mice through a CD8+ T cell-dependent mechanism. Belapectin binds to Gal-3 with affinity Ki of 2.8 μM[1][2].
Target Antigen
Apoptosis; Galectin
Type
Reference compound
Related Pathways
Apoptosis;Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/belapectin.html
Purity
99.33
Solubility
10 mM in DMSO
Smiles
[Belapectin]
References & Citations
[1]Sturgill ER, et al. Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity. Oncoimmunology. 2021 Mar 1;10(1):1892265. |[2]Capasso D, et al. Galectins detection for the diagnosis of chronic diseases: An emerging biosensor approach[J]. TrAC Trends in Analytical Chemistry, 2023: 116952.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-114440/Belapectin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-114440/Belapectin-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1980787-47-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1074647-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details MBS1074647-02 0.02 mg (Yeast)
Recombinant Haemophilus influenzae Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details